Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Natural Killer cell activation, reduced ACE2, TMPRSS2, cytokines G-CSF, M-CSF and SARS-CoV-2-S pseudovirus infectivity by MEK inhibitor treatment of human cells

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.08.02.230839Source: DataRank Database

Natural Killer cell activation, reduced ACE2, TMPRSS2, cytokines G-CSF, M-CSF and SARS-CoV-2-S pseudovirus infectivity by MEK inhibitor treatment of human cells is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2020). On theSindex it has a DataRank of 0. It has been cited 14 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access14 citations

Download PDF

Cite:

Linked data & code

gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: greenTopics (26)IDs (PubMed, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (21)

Kelsey E. Huntington ORCID,Shengliang Zhang ORCID,Lindsey Carlsen ORCID,Eui‐Young So,Cassandra Parker ORCID

Live enrichment

PubMed:32793908 OpenAlex:https://openalex.org/W3046699410

NIGMS NIH HHS

Grant: P20 GM119943

NIGMS NIH HHS

Grant: P30 GM122732

NIGMS NIH HHS

Grant: U54 GM115677

greenLicense: cc-by-nc-nd

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2020/09/02/2020.08.02.230839.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2020.08.02.230839

repositoryhttps://doi.org/10.1101/2020.08.02.230839

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32793908

Fields of Study

COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Immune Cell Function and Interaction

Keywords

InfectivityMEK inhibitorCellMAPK/ERK pathwayImmunologyTrametinibInnate immune systemVirusCancer researchMedicineVirologyBiologyImmune systemSignal transductionCell biologyACE2COVID-19G-CSFIL-6M-CSFSARS-CoV-2TMPRSS2pseudovirus

Sustainable Development Goals

SDG 0: Good health and well-being

Natural Killer cell activation, reduced ACE2, TMPRSS2, cytokines G-CSF, M-CSF and SARS-CoV-2-S pseudovirus infectivity by MEK inhibitor treatment of human cells

FAIR Checklist

Authors (21)

Funding (3 grants)

Open Access

Topics

Annotations (Europe PMC)